Cargando…
Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration
The application of autologous mesenchymal stem cells (MSC) for the treatment of bone defects requires two invasive procedures and several weeks of ex vivo cell expansion. To overcome these limitations, the administration of allogeneic MSC may be attractive, because they are anticipated to be immunop...
Autores principales: | Rapp, Anna E., Bindl, Ronny, Erbacher, Annika, Kruchen, Anne, Rojewski, Markus, Schrezenmeier, Hubert, Müller, Ingo, Ignatius, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163925/ https://www.ncbi.nlm.nih.gov/pubmed/30149650 http://dx.doi.org/10.3390/ijms19092526 |
Ejemplares similares
-
Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγ(c)(null) Mice
por: Rapp, Anna E., et al.
Publicado: (2016) -
GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
por: Fekete, Natalie, et al.
Publicado: (2012) -
Similar regeneration of articular cartilage defects with autologous & allogenic chondrocytes in a rabbit model
por: Boopalan, P.R.J.V.C., et al.
Publicado: (2019) -
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
por: Höchsmann, Britta, et al.
Publicado: (2011) -
The Wnt Serpentine Receptor Frizzled-9 Regulates New Bone Formation in Fracture Healing
por: Heilmann, Aline, et al.
Publicado: (2013)